Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara.
Neuroscience Research Institute, University of California, Santa Barbara.
JAMA Netw Open. 2021 Feb 1;4(2):e2037129. doi: 10.1001/jamanetworkopen.2020.37129.
The reopening of colleges and universities in the US during the coronavirus disease 2019 (COVID-19) pandemic is a significant public health challenge. The development of accessible and practical approaches for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in the college population is paramount for deploying recurrent surveillance testing as an essential strategy for virus detection, containment, and mitigation.
To determine the prevalence of SARS-CoV-2 in asymptomatic participants in a university community by using CREST (Cas13-based, rugged, equitable, scalable testing), a CRISPR-based test developed for accessible and large-scale viral screening.
DESIGN, SETTING, AND PARTICIPANTS: For this cohort study, a total of 1808 asymptomatic participants were screened for SARS-CoV-2 using a CRISPR-based assay and a point-of-reference reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) test. Viral prevalence in self-collected oropharyngeal swab samples collected from May 28 to June 11, 2020, and from June 23 to July 2, 2020, was evaluated.
Testing for SARS-CoV-2.
SARS-CoV-2 status, viral load, and demographic information of the study participants were collected.
Among the 1808 participants (mean [SD] age, 27.3 [11.0] years; 955 [52.8%] female), 732 underwent testing from May to early June (mean [SD] age, 28.4 [11.7] years; 392 [53.6%] female). All test results in this cohort were negative. In contrast, 1076 participants underwent testing from late June to early July (mean [SD] age, 26.6 [10.5] years; 563 [52.3%] female), with 9 positive results by RT-qPCR. Eight of these positive samples were detected by the CRISPR-based assay and confirmed by Clinical Laboratory Improvement Amendments-certified diagnostic testing. The mean (SD) age of the positive cases was 21.7 (3.3) years; all 8 individuals self-identified as students. These metrics showed that a CRISPR-based assay was effective at capturing positive SARS-CoV-2 cases in this student population. Notably, the viral loads detected in these asymptomatic cases resemble those seen in clinical samples, highlighting the potential of covert viral transmission. The shift in viral prevalence coincided with the relaxation of stay-at-home measures.
These findings reveal a shift in SARS-CoV-2 prevalence in a young and asymptomatic population and uncover the leading edge of a local outbreak that coincided with rising case counts in the surrounding county and the state of California. The concordance between CRISPR-based and RT-qPCR testing suggests that CRISPR-based assays are reliable and offer alternative options for surveillance testing and detection of SARS-CoV-2 outbreaks, as is required to resume operations in higher-education institutions in the US and abroad.
在美国 2019 年冠状病毒病(COVID-19)大流行期间,大学和学院重新开放是一项重大的公共卫生挑战。为了部署定期监测检测作为病毒检测、控制和缓解的重要策略,开发针对大学生群体中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的便捷实用检测方法至关重要。
使用 CREST(基于 Cas13 的、坚固的、公平的、可扩展的测试)评估大学社区中无症状参与者中 SARS-CoV-2 的流行情况,CREST 是一种为便捷和大规模病毒筛查开发的基于 CRISPR 的测试。
设计、设置和参与者:在这项队列研究中,使用基于 CRISPR 的测定法和参考点逆转录定量聚合酶链反应(RT-qPCR)试验对总共 1808 名无症状参与者进行了 SARS-CoV-2 筛查。评估了 2020 年 5 月 28 日至 6 月 11 日和 6 月 23 日至 7 月 2 日期间从自我采集的咽拭子样本中检测到的病毒流行率。
SARS-CoV-2 检测。
收集了研究参与者的 SARS-CoV-2 状态、病毒载量和人口统计学信息。
在 1808 名参与者中(平均[标准差]年龄为 27.3[11.0]岁;955[52.8%]女性),732 名参与者于 5 月至 6 月初接受了检测(平均[标准差]年龄为 28.4[11.7]岁;392[53.6%]女性)。该队列中的所有检测结果均为阴性。相比之下,1076 名参与者于 6 月下旬至 7 月初接受了检测(平均[标准差]年龄为 26.6[10.5]岁;563[52.3%]女性),其中 9 名通过 RT-qPCR 检测为阳性。其中 8 例阳性样本通过基于 CRISPR 的检测方法检测到,并通过临床实验室改进修正案认证的诊断检测方法得到确认。阳性病例的平均(标准差)年龄为 21.7(3.3)岁;所有 8 人均自认为是学生。这些指标表明,基于 CRISPR 的检测方法可有效捕获该学生群体中的 SARS-CoV-2 阳性病例。值得注意的是,在这些无症状病例中检测到的病毒载量与临床样本相似,突出了潜在的隐匿性病毒传播。病毒流行率的变化与居家限制措施的放宽相吻合。
这些发现揭示了年轻且无症状人群中 SARS-CoV-2 流行率的变化,并揭示了当地疫情的前沿,当地疫情的爆发与周边县和加利福尼亚州的病例数上升同时发生。基于 CRISPR 的检测与 RT-qPCR 检测的一致性表明,基于 CRISPR 的检测方法可靠,并为监测检测和 SARS-CoV-2 疫情的检测提供了替代选择,这是在美国和国外高等教育机构恢复运营所必需的。